MCA- Increase in Additional fees in case of delay in filingW.e.f July 1, 2022, additional fees on form (excluding Annual Filings) will be increased to 18 times from existing 12 times of normal fees.
CSR: Excess CSR paid in ‘PM CARES Fund’ for FY 2019-20 can be offset as CSR spent in F.Y. 2020-21 E-FILE NO. CSR-01/4/2021-CSR-MCA, Dated a21 May 2021 Keeping in view the spread of COVID-19 in India, an appeal dated 30.03.2020 was made to MDs/CEOs of top 1000 companies in terms of market capitalization, to contribute generously to “Prime Minister's Citizen Assistance and Relief in Emergency Situations Fund” (PM CARES Fund). In the appeal, it was mentioned that such contribution may, inter-alia, include the unspent CSR amount, if any, and an amount over and above the minimum prescribed CSR amount for FY 2019-20, which can later be offset against the CSR obligation arising in subsequent financial years. The said appeal was uploaded on the website of the Ministry and sent to e-mails…
MCA registers 1.55 lakh company incorporations in FY 2020-21 During the Financial Year 2020-21, the Ministry of Corporate Affairs (MCA) has registered more than 1.55Lakh company incorporations as compared to 1.22 Lakh companies during FY 2019-20, an increase of about 27%. Similarly, 42,186 Limited Liability Partnerships (LLPs) got incorporated as against 36,176 last year, an increase of about 17%. The increase is significant considering the unprecedented situation faced by the country due to COVID-19 pandemic
It has been decided that RoCs should be directed to accord approval for extension of 3 months beyond the due date by which companies are required to conduct their Annual General Meetings for their financial year 2019-20 ending on 31st March 2020: Ministry of Corporate Affairs In Maharashtra, ROC Pune and ROC Maharashtra issue orders for due date extension. Pune and Mumbai ROC Orders
CSR rules modified to allow drugs, pharma, devices, vaccine companies to support COVID-19 R&D, collaboratively, in publicly funded institutions. Univs, labs should grasp these opportunities, set up collaborative programs for COVID-19 R&D, also get support for other areas